戻る Agenda
Integrating patient voice into value discussions and monitoring outcomes: key considerations from an EU perspective?
Session Chair(s)
Juan Garcia-Burgos, MD, PHD
Head of Public and Stakeholders Engagement Department
European Medicines Agency, Netherlands
Speaker(s)
Experience of patient involved in EMA activities
Julian Isla, MS
Foundation 29, Spain
Director
Experience of patient involved in FDA activities
Theresa Mullin, PHD
FDA, United States
Associate Center Director - CDER
The value of patient views in benefit-risk evaluations and decision-making
Nathalie Bere, MPH
European Medicines Agency, Netherlands
Patient Engagement